newsfilter
← Latest News
GlobeNewswire·

Mersana Therapeutics Announces Second Quarter 2023 Financial Results

Organization fully focused on product candidates and collaborations based on next-generation ADC platformsCapital resources expected to support current operating plan commitments into 2026 CAMBRIDGE, Mass., Aug. 08,